Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Parks

Showing results (581-590 of 627) with videos related to

Pageof 63
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 8, 2006
Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein-protein interaction through structure-based drug designDaniel J Parks, Louis V LaFrance, Raul R Calvo, et al.
Nature|February 15, 2002
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalphaH Eric Xu, Thomas B Stanley, Valerie G Montana, et al.
Molecular Therapy. Nucleic Acids|April 12, 2019
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus MacaquesNorbert Pardi, Celia C LaBranche, Guido Ferrari, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2016
Discovery of novel potent imidazo[1,2-b]pyridazine PDE10a inhibitorsSanath K Meegalla, Hui Huang, Carl R Illig, et al.
Biochemistry|May 23, 2002
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662Lisa M Leesnitzer, Derek J Parks, Randy K Bledsoe, et al.
Journal of Virology|February 4, 2012
Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine designMattia Bonsignori, David C Montefiori, Xueling Wu, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2011
Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthaleneJonathan Y Bass, Justin A Caravella, Lihong Chen, et al.
Journal of Medicinal Chemistry|December 7, 2010
Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonistsDaniel J Parks, William H Parsons, Raymond W Colburn, et al.
Nature Medicine|February 23, 2010
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeysSampa Santra, Hua-Xin Liao, Ruijin Zhang, et al.
Journal of Medicinal Chemistry|May 3, 2002
Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary aminesJon L Collins, Adam M Fivush, Michael A Watson, et al.
Pageof 63

Showing results (581-590 of 627) with videos related to

Sort By:
Pageof 63
Bioorganic & Medicinal Chemistry Letters|April 8, 2006
Enhanced pharmacokinetic properties of 1,4-benzodiazepine-2,5-dione antagonists of the HDM2-p53 protein-protein interaction through structure-based drug designDaniel J Parks, Louis V LaFrance, Raul R Calvo, et al.
Nature|February 15, 2002
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalphaH Eric Xu, Thomas B Stanley, Valerie G Montana, et al.
Molecular Therapy. Nucleic Acids|April 12, 2019
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus MacaquesNorbert Pardi, Celia C LaBranche, Guido Ferrari, et al.
Bioorganic & Medicinal Chemistry Letters|August 6, 2016
Discovery of novel potent imidazo[1,2-b]pyridazine PDE10a inhibitorsSanath K Meegalla, Hui Huang, Carl R Illig, et al.
Biochemistry|May 23, 2002
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662Lisa M Leesnitzer, Derek J Parks, Randy K Bledsoe, et al.
Journal of Virology|February 4, 2012
Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine designMattia Bonsignori, David C Montefiori, Xueling Wu, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2011
Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthaleneJonathan Y Bass, Justin A Caravella, Lihong Chen, et al.
Journal of Medicinal Chemistry|December 7, 2010
Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonistsDaniel J Parks, William H Parsons, Raymond W Colburn, et al.
Nature Medicine|February 23, 2010
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeysSampa Santra, Hua-Xin Liao, Ruijin Zhang, et al.
Journal of Medicinal Chemistry|May 3, 2002
Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary aminesJon L Collins, Adam M Fivush, Michael A Watson, et al.
Pageof 63